Free Trial
NASDAQ:MDBH

MDB Capital 11/12/2024 Earnings Report

MDB Capital logo
$4.55 +0.80 (+21.44%)
Closing price 03:58 PM Eastern
Extended Trading
$4.22 -0.34 (-7.44%)
As of 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDB Capital EPS Results

Actual EPS
-$0.83
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

MDB Capital Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

MDB Capital Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

MDB Capital's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled on Monday, August 11, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

MDB Capital Earnings Headlines

When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More MDB Capital Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MDB Capital? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MDB Capital and other key companies, straight to your email.

About MDB Capital

MDB Capital (NASDAQ:MDBH), through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.

View MDB Capital Profile

More Earnings Resources from MarketBeat